1. Cutaneous Human Papillomaviruses Down-regulate AKT1, whereas AKT2 Up-regulation and Activation Associates with Tumors
    Ryan F.L. O'Shaughnessy et al, 2007, Cancer Research CrossRef
  2. Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
    Ping Wee et al, 2017, Cancers CrossRef
  3. Twist Transcriptionally Up-regulates AKT2 in Breast Cancer Cells Leading to Increased Migration, Invasion, and Resistance to Paclitaxel
    George Z. Cheng et al, 2007, Cancer Research CrossRef
  4. Cultured rat hepatocytes upregulate Akt and ERK in an ErbB-2-dependent manner
    Lawrence A. Scheving et al, 2008, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
  5. Role of Akt Activation in PARP Inhibitor Resistance in Cancer
    Ferenc Gallyas et al, 2020, Cancers CrossRef
  6. Oncogenic Kinase Signaling in Human Neoplasms
    CHRISTOS TSATSANIS et al, 2004, Annals of the New York Academy of Sciences CrossRef
  7. Prognostic Significance of Activated Akt Expression in Melanoma: A Clinicopathologic Study of 292 Cases
    Derek L. Dai et al, 2005, Journal of Clinical Oncology CrossRef
  8. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of Solanum surattense against Hepatocellular Carcinoma
    Hafiz Rameez Khalid et al, 2022, Molecules CrossRef
  9. Short-chain L-3-hydroxyacyl-CoA dehydrogenase: A novel vital oncogene or tumor suppressor gene in cancers
    He Fang et al, 2022, Frontiers in Pharmacology CrossRef
  10. Higher pAkt Expression Predicts a Significant Worse Prognosis in Glioblastomas
    Yoshiyuki SUZUKI et al, 2010, Journal of Radiation Research CrossRef
  11. Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study
    Crina E. Tiron et al, 2021, Current Issues in Molecular Biology CrossRef
  12. PROX1, a Key Mediator of the Anti-Proliferative Effect of Rapamycin on Hepatocellular Carcinoma Cells
    Sora Kwon et al, 2022, Cells CrossRef
  13. Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies
    Jorge A. Garcia et al, 2008, Molecular Cancer Therapeutics CrossRef
  14. Melatonin as a Radio-Sensitizer in Cancer
    Carolina Alonso-González et al, 2020, Biomedicines CrossRef
  15. Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment
    Mariam Mroweh et al, 2021, International Journal of Molecular Sciences CrossRef